31
Participants
Start Date
March 31, 2013
Primary Completion Date
November 30, 2014
Study Completion Date
December 31, 2014
LiRIS 400 mg
LiRIS 400 mg contains lidocaine which is gradually released into the bladder over 14 days.
LiRIS Placebo
LiRIS Placebo contains lactose, inactive substance.
North Shore - Long Island Jewish Heath System - Monter Cancer Center, New Hyde Park
Premier Medical Group of the Hudson Valley PC, Newburgh
Premier Medical Group of the Hudson Valley PC, Poughkeepsie
Wake Forest Baptist Health, Winston-Salem
Alliance Urology Specialists, PA, Greensboro
Medical University of South Carolina, Charleston
Carolina Urologic Research Center, Myrtle Beach
Atlantic Urological Associates, Daytona Beach
Volunteer Research Group, University of Tennessee Medical Center, Knoxville
MetroHealth Medical Center, Cleveland
William Beaumont Hospitals, Royal Oak
Female Pelvic Medicine & Urogynecology Institute of MI, Grand Rapids
University of Kansas Medical Center, Kansas City
Citrus Valley Medical Research , Inc., Glendora
The UrogynecologyCenter, LLC, Overland Park
Exdeo Clinical Research Inc., Abbotsford
Centre for Applied Urological Research, Kingston
Lead Sponsor
TARIS Biomedical, Inc.
INDUSTRY
Allergan
INDUSTRY